Concepedia

Elisabetta Loggi

EL

Statistics

Publications

32

Citations

2K

H-Index

19

Active since

2003

Affiliations

University of Bologna(Current)

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Massachusetts General Hospital

Ospedale di Parma

Harvard University

Elisabetta Loggi is an author at University of Bologna specializing in viral hepatitis, infectious diseases, and antiviral therapy.

Publications per year

2003–2024

32

Publications

32

Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B

Paola Fisicaro, Caterina Valdatta, Marco Massari et al. · Gastroenterology · 2009 · 492 citations · Full text

Medicine, Cell Biology, Immunology +16

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B

L. Micco, Dimitra Peppa, Elisabetta Loggi et al. · Journal of Hepatology · 2012 · 250 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV

Paola Fisicaro, Caterina Valdatta, Marco Massari et al. · Gastroenterology · 2012 · 125 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire

Anthony T. Tan, Elisabetta Loggi, Carolina Boni et al. · Journal of Virology · 2008 · 122 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies

Velia Chiara Di Maio, Valeria Cento, Ilaria Lenci et al. · Liver International · 2017 · 90 citations · Full text

Life Sciences, Infectious Diseases, Clinical Pharmacology +11

1–5 of 32